The socioeconomic burden of chronic lung disease in low-resource settings across the globe - an observational FRESH AIR studyFRESH AIR Collaborators, Brakema, E. A., Tabyshova, A., van der Kleij, R. M. J. J., Sooronbaev, T., Lionis, C., Anastasaki, M., Pham Le An, T., Luan Than Nguyen, Kirenga, B., Walusimbi, S., Postma, M. J., Chavannes, N. H. & van Boven, J. F. M., 21-Dec-2019, In : Respiratory Research. 20, 1, 10 p., 291.
Research output: Contribution to journal › Article › Academic › peer-review
- Value, Affordability and Sustainability (VALUE)
- Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET)
- Microbes in Health and Disease (MHD)
- PharmacoTherapy, Epidemiology and Economics
- Methods in Medicines evaluation & Outcomes research (M2O)
- Pharmacoepidemiology and Pharmacoeconomics
- Groningen Research Institute for Asthma and COPD (GRIAC)
BACKGROUND: Low-resource settings are disproportionally burdened by chronic lung disease due to early childhood disadvantages and indoor/outdoor air pollution. However, data on the socioeconomic impact of respiratory diseases in these settings are largely lacking. Therefore, we aimed to estimate the chronic lung disease-related socioeconomic burden in diverse low-resource settings across the globe. To inform governmental and health policy, we focused on work productivity and activity impairment and its modifiable clinical and environmental risk factors.
METHODS: We performed a cross-sectional, observational FRESH AIR study in Uganda, Vietnam, Kyrgyzstan, and Greece. We assessed the chronic lung disease-related socioeconomic burden using validated questionnaires among spirometry-diagnosed COPD and/or asthma patients (total N = 1040). Predictors for a higher burden were studied using multivariable linear regression models including demographics (e.g. age, gender), health parameters (breathlessness, comorbidities), and risk factors for chronic lung disease (smoking, solid fuel use). We applied identical models per country, which we subsequently meta-analyzed.
RESULTS: Employed patients reported a median [IQR] overall work impairment due to chronic lung disease of 30% [1.8-51.7] and decreased productivity (presenteeism) of 20.0% [0.0-40.0]. Remarkably, work time missed (absenteeism) was 0.0% [0.0-16.7]. The total population reported 40.0% [20.0-60.0] impairment in daily activities. Breathlessness severity (MRC-scale) (B = 8.92, 95%CI = 7.47-10.36), smoking (B = 5.97, 95%CI = 1.73-10.22), and solid fuel use (B = 3.94, 95%CI = 0.56-7.31) were potentially modifiable risk factors for impairment.
CONCLUSIONS: In low-resource settings, chronic lung disease-related absenteeism is relatively low compared to the substantial presenteeism and activity impairment. Possibly, given the lack of social security systems, relatively few people take days off work at the expense of decreased productivity. Breathlessness (MRC-score), smoking, and solid fuel use are potentially modifiable predictors for higher impairment. Results warrant increased awareness, preventive actions and clinical management of lung diseases in low-resource settings from health policymakers and healthcare workers.
|Number of pages||10|
|Publication status||Published - 21-Dec-2019|
- Chronic respiratory disease, Chronic lung disease, Obstructive lung disease, WPAI, Health economics, Low-income population, Work, Low-resource countries, Household air pollution, OBSTRUCTIVE PULMONARY-DISEASE, QUALITY-OF-LIFE, WORK PRODUCTIVITY, ACTIVITY IMPAIRMENT, ASTHMA CONTROL, COPD, HEALTH, OUTCOMES, IMPACT, ASSOCIATION